CVS Health Corporation Reports 2025 Annual Performance: Growth Amidst Challenges
CVS Health Corporation, a prominent player in the U.S. healthcare landscape, published its 2025 annual report, showcasing a year characterized by significant revenue growth across all operational segments but also marked by substantial challenges, including litigation costs and impairment charges. This article delves into the key highlights from the report, including financial performance, segment breakdowns, and strategic initiatives.
1. Overview of Business Operations
As of December 31, 2025, CVS Health operates nearly 9,000 retail locations and over 1,000 walk-in and primary care medical clinics. The company serves around 87 million plan members through its pharmacy benefits management services and offers a variety of health insurance products, including Medicare Advantage plans reaching over 37 million individuals. CVS Health's integrated model aims to enhance care delivery, leveraging technology to improve health outcomes while striving to reduce overall healthcare costs.
Revenue Breakdown by Segments
The company's operations are grouped into four primary segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Each segment demonstrated growth compared to the previous year, with notable contributions outlined below.
- Health Care Benefits: Revenue surged by $12.7 billion, or 9.7%, to $143.2 billion. This increase was primarily fueled by growth in the Government business, particularly influenced by the Inflation Reduction Act's effects on Medicare Part D.
- Health Services: This segment saw revenues rise by $16.8 billion, or 9.7%, totaling $164.6 billion, driven by favorable pharmacy drug mix and inflation in brand drugs. However, it faced challenges with a significant $5.7 billion goodwill impairment charge.
- Pharmacy & Consumer Wellness: Revenues increased by $14.9 billion, or 11.9%, reaching $93.72 billion, propelled by higher prescription volumes and acquisitions from Rite Aid.
- Corporate/Other: This segment reported a modest revenue increase of $33 million, or 7.3%, totaling $484 million, driven by higher net investment income.
2. Financial Highlights
CVS Health's total revenues for 2025 amounted to $402 billion, reflecting a 7.8% increase from the previous year, with operating expenses also rising by 7.8% to $397.4 billion. However, operating income took a hit, decreasing by 45.3% to $4.66 billion, largely due to the goodwill impairment and litigation charges.
Income Statement Overview
The following table summarizes the income statement for 2024 and 2025:
| Feb 2025 | Feb 2026 | |
|---|---|---|
Net Income | 4.61B | 1.76B |
Net Income to Non-controlling Interest | -28M | -40M |
Profit | 4.58B | 1.72B |
Net Income Continuing | 4.58B | 1.72B |
Income Tax Expense | 1.56B | 408M |
Pretax Income | 6.14B | 2.13B |
Non-operating Income | -2.36B | -2.52B |
Operating Income | 8.51B | 4.66B |
Revenue | 372.8B | 402.0B |
Costs and Expenses | 364.2B | 397.4B |
Cost of Revenue | 321.4B | 346.7B |
Operating Expenses | 42.88B | 50.70B |
Impairment Expense | 0 | 5.72B |
Other Operating Expenses | 42.88B | 44.97B |
- Net Income: Decreased to $1.76 billion from $4.61 billion in 2024, indicating a significant drop driven by increased expenses.
- Costs and Expenses: Rose to $397.4 billion, with impairment and litigation charges heavily impacting profitability.
3. Balance Sheet Analysis
CVS Health's balance sheet reflects a stable financial position with total assets valued at $253.5 billion in 2025, a slight increase from $253.2 billion in 2024. The company maintains a balanced ratio of liabilities to equity, with total liabilities at $178.1 billion and total equity at $75.4 billion.
| Feb 2025 | Feb 2026 | |
|---|---|---|
Total Assets | 253.2B | 253.5B |
Total Current Assets | 68.64B | 74.71B |
Cash and Equivalents | 8.58B | 8.45B |
Short-term Investments | 2.40B | 2.14B |
Net Inventories | 18.10B | 19.24B |
Accounts Receivable | 36.46B | 39.77B |
Other Current Assets | 3.07B | 5.09B |
Total Non-current Assets | 184.5B | 178.8B |
Intangible Assets | 118.5B | 110.9B |
Long-term Investments | 28.93B | 32.66B |
Net PP&E | 12.99B | 13.08B |
Lease Assets | 15.94B | 14.97B |
Other Non-current Assets | 8.10B | 7.11B |
Total Liabilities and Equity | 253.2B | 253.5B |
Total Liabilities | 177.4B | 178.1B |
Total Current Liabilities | 84.60B | 88.69B |
Accounts Payable and Accrued Liabilities | 36.70B | 40.02B |
Current Debt | 7.49B | 5.80B |
Other Current Liabilities | 40.41B | 42.85B |
Total Non-current Liabilities | 92.87B | 89.46B |
Long-term Debt | 60.52B | 60.50B |
Non-current Deferred Tax Liabilities | 3.80B | 3.83B |
Other Non-current Liabilities | 28.54B | 25.13B |
Total Equity and Non-controlling Interests | 75.73B | 75.38B |
Total Equity | 75.56B | 75.21B |
Non-controlling Interests | 170M | 168M |
Key Changes and Challenges
2025 proved to be a challenging year for CVS Health, primarily due to a $5.7 billion goodwill impairment charge linked to its Health Care Delivery reporting unit. Legal issues also loomed large, with $1.2 billion in litigation costs associated with opioid-related lawsuits. The company's management team has been restructured to better address these ongoing challenges, particularly in the Health Care Delivery segment, which has seen a strategic reduction in the number of new clinics planned for 2026.
4. Cash Flow Statement Overview
Cash flow from operating activities increased to $10.63 billion, although the company reported a net change in cash of -$172 million due to extensive investment and financing activities, including significant payments related to acquisitions and share repurchases.
| Feb 2025 | Feb 2026 | |
|---|---|---|
Net Change in Cash | 359M | -172M |
Net Cash from Operating Activities | 9.10B | 10.63B |
Operating Profit | 4.58B | 1.72B |
Adjustment to Operating Profit | 4.52B | 8.91B |
Net Cash from Investing Activities | -7.61B | -5.87B |
Business & Interest in Affiliates | 95M | 436M |
Investments | 4.83B | 2.62B |
Productive Assets | 2.78B | 2.83B |
Other Investing Activities | 101M | 26M |
Net Cash from Financing Activities | -1.13B | -4.94B |
Debt | 5.05B | -1.77B |
Dividends | 3.37B | 3.39B |
Equity Issuance/Repurchase | -2.66B | 394M |
Other Financing Activities | -159M | -158M |
5. Strategic Acquisitions and Future Outlook
In its ongoing efforts to enhance healthcare delivery capabilities, CVS Health has continued to integrate its acquisitions of Signify Health and Oak Street Health. These strategic moves are indicative of the company's commitment to value-based care, aimed at improving health outcomes and redefining traditional healthcare delivery models.
6. Conclusion
CVS Health Corporation's 2025 annual report illustrates a year of robust revenue growth tempered by significant operational challenges. While the company has made strides in expanding its service offerings and enhancing integrated care, it must navigate the complexities of ongoing litigation and market pressures. Looking ahead, CVS Health is focused on leveraging its technology-driven model to improve care delivery while maintaining a keen eye on financial stability and operational efficiency.
